Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...

President Donald Trump is weighing whether to reclassify cannabis as a less dangerous drug. People familiar with the matter ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

American shoppers hit with 60% of costs as import taxes reach 100-year high - Tariffs on U.S. trading partners finally in full effect months after ‘Liberation Day’ announcement and ensuing turmoil and ...

Apple and Trump detail $100 billion U.S. spending expansion: Here's what to know Brandon Blackstock, Kelly Clarkson's ...

Trump told CNBC he will initially impose a “small tariff” on pharmas in the next week or so, but will raise it to 150% in a ...

When President Donald Trump hits "post" on Truth Social, Wall Street braces for impact. What Happened: Various stock prices — ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...